Improved gene silencing capabilities with minivector DNAs

Baylor College of Medicine, in conjunction with The Methodist Hospital Research Institute, has developed a way to use minivector DNAs in gene therapy. These reduced sized DNA vectors (as small as 300bp) have high gene silencing capabilities and high serum survival lengths with low replenishment requirements. In addition, the study shows that DNA minivectors have improved transfection efficiencies in aortic smooth muscle and NIH 3T3 cells. Minivector DNAs are a promising new gene therapy tool, particularly for blood-borne diseases such as lymphoma.

Zhao, N., J M Fogg, L Zechiedrich, and Y Zu.
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells.”  Gene Therapy  21 October 2010.



Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

One Response to Improved gene silencing capabilities with minivector DNAs

  1. Pingback: Plasmid DNA 101 | VGXI Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s